# Clinical Evaluation of the Combination of Symptoms and Symptoms With General Treatment for Acute Hemorrhagic Stroke

> **NCT04946474** · PHASE4 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 520 (estimated)

## Conditions studied

- Acute Hemorrhagic Stroke

## Interventions

- **DRUG:** Xingnaojing injection + Shuxuetong oral liquid

## Key facts

- **NCT ID:** NCT04946474
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2021-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04946474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04946474, "Clinical Evaluation of the Combination of Symptoms and Symptoms With General Treatment for Acute Hemorrhagic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04946474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*